Animal models of insulin resistance: A review

Pharmacological Reports

Volumn 68, Issue 6, 2016, Pages 1165-1177

  Sah, Sangeeta Pilkhwal ^a   Singh, Barinder ^a   Choudhary, Supriti ^a   Kumar, Anil ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Genetic models; HOMA index; Insulin receptor substrates; Insulin resistance

Indexed keywords

ALCOHOL; DEXAMETHASONE; FAT; FRUCTOSE; GLUCOSE OXIDASE; INSULIN; LONG ACTING INSULIN; SODIUM CHLORIDE; STREPTOZOCIN; SUCROSE; ZYMOSAN;

ANIMAL MODEL; BHE RAT; CAFETERIA DIET; CARBOHYDRATE DIET; COHEN RAT; DIET; EXERCISE; GENE MUTATION; GENETIC MODEL; GOTO KAKIZAKI RAT; HUMAN; IMMOBILITY; INJURY; INSULIN RESISTANCE; JCR LA CP RAT; KK-AY MOUSE; KOLETSKY RAT; KUO KONDO MICE; LIPID DIET; LIPODYSTROPHY; NEW ZEALAND OBESE MICE; NONCNZO10 LTJ MICE; NONHUMAN; OBESITY; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PHYSICAL INJURY; PREGNANCY; RAT MODEL; RAT STRAIN; REVIEW; RISK FACTOR; SALT INTAKE; SCREENING; SLEEP DEPRIVATION; STRESS; TALLYHO MOUSE; THERMAL INJURY; WDF TA FA RAT; ZUCKER RAT; ANIMAL; DISEASE MODEL; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; GLUCOSE INTOLERANCE; HUMANS; INSULIN RESISTANCE; OBESITY;

EID: 84988036813     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2016.07.010     Document Type: Review

References (117)

1. [1] Martin, S.D., McGee, S.L., The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes. Biochim Biophys Acta 1840 (2014), 1303–1312.
2. [2] Misra, P., Upadhyay, R.P., Misra, A., Anand, K., A review of the epidemiology of diabetes in rural India. Diabetes Res Clin Pract 92 (2011), 303–311.
3. [3] Nandi, A., Kitamura, Y., Kahn, C.R., Accili, D., Mouse models of insulin resistance. Physiol Rev 84 (2004), 623–647.
4. [4] Duque-Guimaraes, D.E., Ozanne, S.E., Nutritional programming of insulin resistance: causes and consequences. Trends Endocrinol Metab 24 (2013), 525–535.
5. [5] Wang, X., Gu, C., He, W., Ye, X., Chen, H., Zhang, X., et al. Glucose oxidase induces insulin resistance via influencing multiple targets in vitro and in vivo: the central role of oxidative stress. Biochimie 94 (2012), 1705–1717.
6. [6] Defronzo, R.A., Banting Lecture From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 58 (2009), 773–795.
7. [7] Hishinuma, A., Majima, M., Kurabayashi, H., Insulin resistance in patients with stroke is related to visceral fat obesity and adipocytokines. J Stroke Cerebrovasc Dis 17 (2008), 175–180.
8. [8] Burgering, B.M., Coffer, P.J., Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376 (1995), 599–602.
9. [9] Wheatcroft, S.B., Williams, I.L., Shah, A.M., Kearney, M.T., Pathophysiological implications of insulin resistance on vascular endothelial function. Diabet Med 20 (2003), 255–268.
10. [10] Ropelle, E.R., Flores, M.B., Cintra, D.E., Rocha, G.Z., Pauli, J.R., Morari, J., et al. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKβ and ER stress inhibition. PLoS Biol, 8, 2010, 1812.
11. [11] Shoelson, S.E., Lee, J., Goldfine, A.B., Inflammation and insulin resistance. J Clin Invest 116 (2006), 1793–1801.
12. [12] Qatanani, M., Lazar, M.A., Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21 (2007), 1443–1455.
13. [13] Kawai, T., Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11 (2010), 373–384.
14. [14] Nakatani, Y., Kaneto, H., Kawamori, D., Yoshiuchi, K., Hatazaki, M., Matsuoka, T.a., et al. Involvement of endoplasmic reticulum stress in insulin resistance and diabetes. J Biol Chem 280 (2005), 847–851.
15. [15] Samuel, V.T., Shulman, G.I., Mechanisms for insulin resistance: common threads and missing links. Cell 148 (2012), 852–871.
16. [16] Burén, J., Eriksson, J.W., Is insulin resistance caused by defects in insulin's target cells or by a stressed mind. Diabetes Metab Res Rev 21 (2005), 487–494.
17. [17] Sjöstrand, M., Eriksson, J.W., Neuroendocrine mechanisms in insulin resistance. Mol Cell Endocrinol 297 (2009), 104–111.
18. [18] Karam, J., Forsham, P., Pancreatic hormones and diabetes mellitus. Basic and Clinical Endocrinology, 1997, Appleton & Lange, Stamford CT USA, 601–602.
19. [19] Kahn, S.E., McCulloch, D.K., Porte, D. Jr, Insulin secretion in the normal and diabetic human. International Textbook of Diabetes Mellitus, 2nd edn, 1997, J Wiley & Sons, New York, 338–353.
20. [20] Bray, G.A., Lovejoy, J.C., Smith, S.R., DeLany, J.P., Lefevre, M., Hwang, D., et al. The influence of different fats and fatty acids on obesity, insulin resistance and inflammation. J Nutr 132 (2002), 2488–2491.
21. [21] Toida, S., Takahashi, M., Shimizu, H., Sato, N., Shimomura, Y., Kobayashi, I., Effect of high sucrose feeding on fat accumulation in the male Wistar rat. Obes Res 4 (1996), 561–568.
22. [22] Linn, T., Santosa, B., Gronemeyer, D., Aygen, S., Scholz, N., Busch, M., et al. Effect of long-term dietary protein intake on glucose metabolism in humans. Diabetologia 43 (2000), 1257–1265.
23. [23] Wilcox, G., Insulin and insulin resistance. Clin Biochem Rev 26 (2005), 19–39.
24. [24] Marette, A., Molecular mechanisms of inflammation in obesity-linked insulin resistance. Int J Obes Relat Metab Disord 27:Suppl. 3 (2003), S46–S48.
25. [25] Hirose, M., Kaneki, M., Sugita, H., Yasuhara, S., Martyn, J.A., Immobilization depresses insulin signaling in skeletal muscle. Am J Physiol Endocrinol Metab 279 (2000), E1235–E1241.
26. [26] Aronne, L.J., Segal, K.R., Adiposity and fat distribution outcome measures: assessment and clinical implications. Obes Res 10:Suppl. 1 (2002), 14S–21S.
27. [27] Kahn, B.B., Flier, J.S., Obesity and insulin resistance. J Clin Invest 106 (2000), 473–481.
28. [28] Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A.L., et al. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283 (1999), 1544–1548.
29. [29] Vorona, R.D., Winn, M.P., Babineau, T.W., Eng, B.P., Feldman, H.R., Ware, J.C., Overweight and obese patients in a primary care population report less sleep than patients with a normal body mass index. Arch Intern Med 165 (2005), 25–30.
30. [30] Hew, F., O'Neal, D., Kamarudin, N., Alford, F., Best, J., 1 Growth hormone deficiency and cardiovascular risk. Baillieres Clin Endocrinol Metab 12 (1998), 199–216.
31. [31] Halvatsiotis, P., Turk, D., Alzaid, A., Dinneen, S., Rizza, R., Nair, K., Insulin effect on leucine kinetics in type 2 diabetes mellitus. Diabetes Metab Res 15 (2002), 136–142.
32. [32] Dohm, G.L., Invited review: regulation of skeletal muscle GLUT-4 expression by exercise. J Appl Physiol (1985) 93 (2002), 782–787.
33. [33] Henriksen, E.J., Invited review: effects of acute exercise and exercise training on insulin resistance. J Appl Physiol (1985) 93 (2002), 788–796.
34. [34] Lee, J.M., Okumura, M.J., Davis, M.M., Herman, W.H., Gurney, J.G., Prevalence and determinants of insulin resistance among US adolescents a population-based study. Diabetes Care 29 (2006), 2427–2432.
35. [35] Ye, J., Mechanisms of insulin resistance in obesity. Front Med 7 (2013), 14–24.
36. [36] Ehses, J., Meier, D., Wueest, S., Rytka, J., Boller, S., Wielinga, P., et al. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 53 (2010), 1795–1806.
37. [37] Davis, J.E., Braucher, D.R., Walker-Daniels, J., Spurlock, M.E., Absence of Tlr2 protects against high-fat diet-induced inflammation and results in greater insulin-stimulated glucose transport in cultured adipocytes. J Nutr Biochem 22 (2011), 136–141.
38. [38] Lee, Y.S., Li, P., Huh, J.Y., Hwang, I.J., Lu, M., Kim, J.I., et al. Inflammation is necessary for long-term but not short-term high-fat diet–induced insulin resistance. Diabetes 60 (2011), 2474–2483.
39. [39] Leung, N., Naples, M., Uffelman, K., Szeto, L., Adeli, K., Lewis, G.F., Rosiglitazone improves intestinal lipoprotein overproduction in the fat-fed Syrian Golden hamster, an animal model of nutritionally-induced insulin resistance. Atherosclerosis 174 (2004), 235–241.
40. [40] Ai, J., Wang, N., Yang, M., Du, Z.M., Zhang, Y.C., Yang, B.F., Development of Wistar rat model of insulin resistance. World J Gastroenterol 11 (2005), 3675–3679.
41. [41] Bonner, J.S., Lantier, L., Hocking, K.M., Kang, L., Owolabi, M., James, F.D., et al. Relaxin treatment reverses insulin resistance in mice fed a high-fat diet. Diabetes 62 (2013), 3251–3260.
42. [42] Fraulob, J.C., Ogg-Diamantino, R., Fernandes-Santos, C., Aguila, M.B., Mandarim-de-Lacerda, C.A., A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr, 46, 2010, 212.
43. [43] Yan, J., Zhao, Y., Suo, S., Liu, Y., Zhao, B., Green tea catechins ameliorate adipose insulin resistance by improving oxidative stress. Free Radic Biol Med 52 (2012), 1648–1657.
44. [44] Higa, T.S., Spinola, A.V., Fonseca-Alaniz, M.H., Evangelista, F., Comparison between cafeteria and high-fat diets in the induction of metabolic dysfunction in mice. Int J Physiol Pathophysiol Pharmacol 6 (2014), 47–54.
45. [45] Brandt, N., De Bock, K., Richter, E.A., Hespel, P., Cafeteria diet-induced insulin resistance is not associated with decreased insulin signaling or AMPK activity and is alleviated by physical training in rats. Am J Physiol Endocrinol Metab 299 (2010), E215–E224.
46. [46] Pinto Júnior, D.A.C., Seraphim, P.M., Cafeteria diet intake for fourteen weeks can cause obesity and insulin resistance in Wistar rats. Revista de Nutriúço 25 (2012), 313–319.
47. [47] Gonzalez-Abuin, N., Martinez-Micaelo, N., Blay, M., Ardevol, A., Pinent, M., Grape-seed procyanidins prevent the cafeteria-diet-induced decrease of glucagon-like peptide-1 production. J Agric Food Chem 62 (2014), 1066–1072.
48. [48] Brandimarti, P., Costa-Junior, J.M., Ferreira, S.M., Protzek, A.O., Santos, G.J., Carneiro, E.M., et al. Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing. J Endocrinol 219 (2013), 173–182.
49. [49] Basciano, H., Federico, L., Adeli, K., Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond), 2, 2005, 5.
50. [50] Naples, M., Federico, L.M., Xu, E., Nelken, J., Adeli, K., Effect of rosuvastatin on insulin sensitivity in an animal model of insulin resistance: evidence for statin-induced hepatic insulin sensitization. Atherosclerosis 198 (2008), 94–103.
51. [51] Maithilikarpagaselvi, N., Sridhar, M.G., Swaminathan, R.P., Zachariah, B., Curcumin prevents inflammatory response, oxidative stress and insulin resistance in high fructose fed male Wistar rats: potential role of serine kinases. Chem Biol Interact 244 (2016), 187–194.
52. [52] Castro, M.C., Massa, M.L., Arbeláez, L.G., Schinella, G., Gagliardino, J.J., Francini, F., Fructose-induced inflammation, insulin resistance and oxidative stress: a liver pathological triad effectively disrupted by lipoic acid. Life Sci 137 (2015), 1–6.
53. [53] Maged, A., Haroun, N.M., Laila, A., Elsayed, M., Laila, A., Rashed, M., Mohammed, M.A., The effect of high fat diet and high fructose intake on insulin resistance and GLP-1 in experimental animals. Med J Cairo Univ, 2011, 79.
54. [54] Del Toro-Equihua, M., Velasco-Rodríguez, R., López-Ascencio, R., Vásquez, C., Effect of an avocado oil-enhanced diet (Persea americana) on sucrose-induced insulin resistance in Wistar rats. J Food Drug Anal 24 (2016), 350–357.
55. [55] Soria, A., Chicco, A., Eugenia D'Alessandro, M., Rossi, A., Lombardo, Y.B., Dietary fish oil reverse epididymal tissue adiposity, cell hypertrophy and insulin resistance in dyslipemic sucrose fed rat model small star, filled. J Nutr Biochem 13 (2002), 209–218.
56. [56] Couturier, K., Qin, B., Batandier, C., Awada, M., Hininger-Favier, I., Canini, F., et al. Cinnamon increases liver glycogen in an animal model of insulin resistance. Metabolism 60 (2011), 1590–1597.
57. [57] Lozano, I., Van der Werf, R., Bietiger, W., Seyfritz, E., Peronet, C., Pinget, M., et al. High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutr Metab (Lond), 13, 2016, 1.
58. [58] Li, Y., Tran, V.H., Kota, B.P., Nammi, S., Duke, C.C., Roufogalis, B.D., Preventative effect of zingiber officinale on insulin resistance in a high-fat high-carbohydrate diet-fed rat model and its mechanism of action. Basic Clin Pharmacol Toxicol 115 (2014), 209–215.
59. [59] Ning, B., Wang, X., Yu, Y., Waqar, A.B., Yu, Q., Koike, T., et al. High-fructose and high-fat diet-induced insulin resistance enhances atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Nutr Metab (Lond), 12, 2015, 30.
60. [60] Ogihara, T., Asano, T., Ando, K., Chiba, Y., Sekine, N., Sakoda, H., et al. Insulin resistance with enhanced insulin signaling in high-salt diet-fed rats. Diabetes 50 (2001), 573–583.
61. [61] Ogihara, T., Asano, T., Ando, K., Sakoda, H., Anai, M., Shojima, N., et al. High-salt diet enhances insulin signaling and induces insulin resistance in Dahl salt-sensitive rats. Hypertension 40 (2002), 83–89.
62. [62] Premilovac, D., Richards, S.M., Rattigan, S., Keske, M.A., A vascular mechanism for high-sodium-induced insulin resistance in rats. Diabetologia 57 (2014), 2586–2595.
63. [63] Williams, V.L., Martin, R.E., Franklin, J.L., Hardy, R.W., Messina, J.L., Injury-induced insulin resistance in adipose tissue. Biochem Biophys Res Commun 421 (2012), 442–448.
64. [64] Carter, E.A., Insulin resistance in burns and trauma. Nutr Rev 56 (1998), S170–S176.
65. [65] Carter, E.A., Burks, D., Fischman, A.J., White, M., Tompkins, R.G., Insulin resistance in thermally-injured rats is associated with post-receptor alterations in skeletal muscle, liver and adipose tissue. Int J Mol Med 14 (2004), 653–661.
66. [66] Xin-Long, C., Zhao-Fan, X., Dao-Feng, B., Jian-Guang, T., Duo, W., Insulin resistance following thermal injury: an animal study. Burns 33 (2007), 480–483.
67. [67] Shen C-a Fagan, S., Fischman, A.J., Carter, E.E., Chai, J.-K., Lu, X.-M., et al. Effects of glucagon-like peptide 1 on glycemia control and its metabolic consequence after severe thermal injury—studies in an animal model. Surgery 149 (2011), 635–644.
68. [68] Gauglitz, G.G., Herndon, D.N., Jeschke, M.G., Insulin resistance post-burn: underlying mechanisms and current therapeutic strategies. J Burn Care Res, 29, 2008, 683.
69. [69] Sugita, M., Sugita, H., Kim, M., Mao, J., Yasuda, Y., Habiro, M., et al. Inducible nitric oxide synthase deficiency ameliorates skeletal muscle insulin resistance but does not alter unexpected lower blood glucose levels after burn injury in C57BL/6 mice. Metabolism 61 (2012), 127–136.
70. [70] Ma, Y., Toth, B., Keeton, A.B., Holland, L.T., Chaudry, I.H., Messina, J.L., Mechanisms of hemorrhage-induced hepatic insulin resistance: role of tumor necrosis factor-α. Endocrinology 145 (2004), 5168–5176.
71. [71] Thompson, L.H., Kim, H.T., Ma, Y., Kokorina, N.A., Messina, J.L., Acute, muscle-type specific insulin resistance following injury. Mol Med 14 (2008), 715–723.
72. [72] Kang, L., Sebastian, B.M., Pritchard, M.T., Pratt, B.T., Previs, S.F., Nagy, L.E., Chronic ethanol-induced insulin resistance is associated with macrophage infiltration into adipose tissue and altered expression of adipocytokines. Alcohol Clin Exp Res 31 (2007), 1581–1588.
73. [73] Lindtner, C., Scherer, T., Zielinski, E., Filatova, N., Fasshauer, M., Tonks, N.K., et al. Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action. Sci Transl Med, 5, 2013 170ra14-ra14.
74. [74] de la Monte, S., Derdak, Z., Wands, J.R., Alcohol, insulin resistance and the liver-brain axis. J Gastroenterol Hepatol 27:Suppl. 2 (2012), 33–41.
75. [75] King, A.J., The use of animal models in diabetes research. Br J Pharmacol 166 (2012), 877–894.
76. [76] Damasceno, D.C., Netto, A.O., Iessi, I.L., Gallego, F.Q., Corvino, S.B., Dallaqua, B., et al. Streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomes. Biomed Res Int, 2014, 2014, 819065.
77. [77] Arikawe, A., Oyerinde, A., Olatunji-Bello, I., Obika, L., Streptozotocin diabetes and insulin resistance impairment of spermatogenesis in adult rat testis: central Vs local mechanism. Niger J Physiol Sci 27 (2013), 171–179.
78. [78] Freund, P., Wolff, H., Kühnle, H., (−)-BM 13.0913: A new oral antidiabetic agent that improves insulin sensitivity in animal models of type II (non—insulin-dependent) diabetes mellitus. Metabolism 44 (1995), 570–576.
79. [79] Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C., Ramarao, P., Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. Pharmacol Res 52 (2005), 313–320.
80. [80] Liu, Q., Pioglitazone can ameliorate insulin resistance in low-dose streptozotocin and high sucrose‐fat diet induced obese rats. Acta Pharmacol Sin 26 (2005), 575–580.
81. [81] Jung, J.Y., Lim, Y., Moon, M.S., Kim, J.Y., Kwon, O., Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats. Nutr Metab (Lond), 8, 2011, 18.
82. [82] Saleh, S., El-Maraghy, N., Reda, E., Barakat, W., Modulation of diabetes and dyslipidemia in diabetic insulin-resistant rats by mangiferin: role of adiponectin and TNF-α. Anais Acad Bras Cienc 86 (2014), 1935–1948.
83. [83] Li, L., Li, X., Zhou, W., Messina, J.L., Acute psychological stress results in the rapid development of insulin resistance. J Endocrinol 217 (2013), 175–184.
84. [84] Tsuneki, H., Tokai, E., Sugawara, C., Wada, T., Sakurai, T., Sasaoka, T., Hypothalamic orexin prevents hepatic insulin resistance induced by social defeat stress in mice. Neuropeptides 47 (2013), 213–219.
85. [85] Ruzzin, J., Wagman, A., Jensen, J., Glucocorticoid-induced insulin resistance in skeletal muscles: defects in insulin signalling and the effects of a selective glycogen synthase kinase-3 inhibitor. Diabetologia 48 (2005), 2119–2130.
86. [86] Severino, C., Brizzi, P., Solinas, A., Secchi, G., Maioli, M., Tonolo, G., Low-dose dexamethasone in the rat: a model to study insulin resistance. Am J Physiol Endocrinol Metab 283 (2002), E367–E373.
87. [87] Petit, F., Bagby, G.J., Lang, C.H., Tumor necrosis factor mediates zymosan-induced increase in glucose flux and insulin resistance. Am J Physiol Endocrinol Metab 268 (1995), E219–E228.
88. [88] Wang, L., Ku, P., Chen, S., Chung, H., Yu, Y., Cheng, J., Insulin resistance induced by zymosan as a new animal model in mice. Horm Metab Res 45 (2013), 736–740.
89. [89] Cao, W., Liu, H.-Y., Hong, T., Liu, Z., Excess exposure to insulin may be the primary cause of insulin resistance. Am J Physiol Endocrinol Metab, 298, 2010 E372–E.
90. [90] Yang, X., Mei, S., Gu, H., Guo, H., Zha, L., Cai, J., et al. Exposure to excess insulin (glargine) induces type 2 diabetes mellitus in mice fed on a chow diet. J Endocrinol 221 (2014), 469–480.
91. [91] Cohen, B., Novick, D., Rubinstein, M., Modulation of insulin activities by leptin. Science 274 (1996), 1185–1188.
92. [92] Tartaglia, L.A., Dembski, M., Weng, X., Deng, N., Culpepper, J., Devos, R., et al. Identification and expression cloning of a leptin receptor, OB-R. Cell 83 (1995), 1263–1271.
93. [93] Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994), 425–432.
94. [94] Yekollu, S.K., Thomas, R., O'sullivan, B., Targeting curcusomes to inflammatory dendritic cells inhibits NF-κB and improves insulin resistance in obese mice. Diabetes 60 (2011), 2928–2938.
95. [95] Oana, F., Takeda, H., Hayakawa, K., Matsuzawa, A., Akahane, S., Isaji, M., et al. Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin. Metabolism 54 (2005), 995–1001.
96. [96] Vogel, H.G., Drug discovery and evaluation: pharmacological assays. 2002, Springer Science & Business Media.
97. [97] Ikeda, H., Shino, A., Matsuo, T., Iwatsuka, H., Suzuoki, Z., A new genetically obese-hyperglycemic rat (Wistar fatty). Diabetes 30 (1981), 1045–1050.
98. [98] Galli, J., Li, L.S., Glaser, A., Ostenson, C.G., Jiao, H., Fakhrai-Rad, H., et al. Genetic analysis of non-insulin dependent diabetes mellitus in the GK rat. Nat Genet 12 (1996), 31–37.
99. [99] Aitman, T.J., Glazier, A.M., Wallace, C.A., Cooper, L.D., Norsworthy, P.J., Wahid, F.N., et al. Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21 (1999), 76–83.
100. [100] Gotoda, T., Iizuka, Y., Kato, N., Osuga, J., Bihoreau, M.T., Murakami, T., et al. Absence of Cd36 mutation in the original spontaneously hypertensive rats with insulin resistance. Nat Genet 22 (1999), 226–228.
101. [101] Pravenec, M., Landa, V., Zidek, V., Musilova, A., Kren, V., Kazdova, L., et al. Transgenic rescue of defective Cd36 ameliorates insulin resistance in spontaneously hypertensive rats. Nat Genet 27 (2001), 156–158.
102. [102] Ishida, K., Mizuno, A., Min, Z., Sano, T., Shima, K., Which is the primary etiologic event in Otsuka Long-Evans Tokushima Fatty rats, a model of spontaneous non—insulin-dependent diabetes mellitus, insulin resistance, or impaired insulin secretion. Metabolism 44 (1995), 940–945.
103. [103] Kawano, K., Hirashima, T., Mori, S., Saitoh, Y., Kurosumi, M., Natori, T., Spontaneous long-term hyperglycemic rat with diabetic complications: Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41 (1992), 1422–1428.
104. [104] Srinivasan, K., Ramarao, P., Animal models in type 2 diabetes research: an overview. Indian J Med Res, 125, 2007, 451.
105. [105] Suzuki, W., Iizuka, S., Tabuchi, M., Funo, S., Yanagisawa, T., Kimura, M., et al. A new mouse model of spontaneous diabetes derived from ddY strain. Exp Anim 48 (1999), 181–189.
106. [106] Collier, G., SILVA, A., Sanigorski, A., Walder, K., Yamamoto, A., Zimmet, P., Development of obesity and insulin resistance in the israeli sand rat (Psammomys obesus) does leptin play a role?. Ann N Y Acad Sci 827 (1997), 50–63.
107. [107] Abel, E.D., Peroni, O., Kim, J.K., Kim, Y.-B., Boss, O., Hadro, E., et al. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409 (2001), 729–733.
108. [108] Guillam, M.T., Hummler, E., Schaerer, E., Yeh, J.I., Birnbaum, M.J., Beermann, F., et al. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2. Nat Genet 17 (1997), 327–330.
109. [109] Stenbit, A.E., Tsao, T.S., Li, J., Burcelin, R., Geenen, D.L., Factor, S.M., et al. GLUT4 heterozygous knockout mice develop muscle insulin resistance and diabetes. Nat Med 3 (1997), 1096–1101.
110. [110] Zisman, A., Peroni, O.D., Abel, E.D., Michael, M.D., Mauvais-Jarvis, F., Lowell, B.B., et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 6 (2000), 924–928.
111. [111] Sone, H., Suzuki, H., Takahashi, A., Yamada, N., Disease model: hyperinsulinemia and insulin resistance: part A—targeted disruption of insulin signaling or glucose transport. Trends Mol Med 7 (2001), 320–322.
112. [112] Cho, H., Mu, J., Kim, J.K., Thorvaldsen, J.L., Chu, Q., Crenshaw, E.B. 3rd, et al. Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). Science 292 (2001), 1728–1731.
113. [113] Duan, W., Guo, Z., Jiang, H., Ware, M., Mattson, M.P., Reversal of behavioral and metabolic abnormalities, and insulin resistance syndrome, by dietary restriction in mice deficient in brain-derived neurotrophic factor. Endocrinology 144 (2003), 2446–2453.
114. [114] Yang, C., Coker, K.J., Kim, J.K., Mora, S., Thurmond, D.C., Davis, A.C., et al. Syntaxin 4 heterozygous knockout mice develop muscle insulin resistance. J Clin Invest 107 (2001), 1311–1318.
115. [115] Shimomura, I., Hammer, R.E., Richardson, J.A., Ikemoto, S., Bashmakov, Y., Goldstein, J.L., et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 12 (1998), 3182–3194.
116. [116] Shimano, H., Horton, J.D., Shimomura, I., Hammer, R.E., Brown, M.S., Goldstein JL: isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. Eur J Clin Invest, 99, 1997, 846.
117. [117] Kim, J.K., Gavrilova, O., Chen, Y., Reitman, M.L., Shulman, G.I., Mechanism of insulin resistance in A-ZIP/F-1 fatless mice. J Biol Chem 275 (2000), 8456–8460.